Vilin Bio Med Limited (NSE:VILINBIO)

Vilin Bio Med Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	451	285	265	-	-	-
Market Cap Growth	90.29%	7.37%	-	-	-	-
Enterprise Value	455	297	255	-	-	-
Last Close Price	32.35	20.40	19.00	-	-	-
PE Ratio	179.95	127.33	163.21	-	-	-
PS Ratio	2.26	1.92	1.68	-	-	-
PB Ratio	1.94	1.23	1.16	-	-	-
P/TBV Ratio	1.94	1.23	1.16	-	-	-
P/OCF Ratio	-	130.84	-	-	-	-
EV/Sales Ratio	2.28	2.00	1.61	-	-	-
EV/EBITDA Ratio	64.85	37.70	31.22	-	-	-
EV/EBIT Ratio	76.19	43.47	37.14	-	-	-
Debt / Equity Ratio	0.02	0.11	0.30	0.46	0.72	0.75
Debt / EBITDA Ratio	0.65	3.27	8.36	1.90	6.88	6.41
Debt / FCF Ratio	-	-	-	-	25.39	-
Net Debt / Equity Ratio	0.02	0.11	0.03	0.46	0.71	0.74
Net Debt / EBITDA Ratio	0.52	3.20	0.96	1.89	6.83	6.36
Net Debt / FCF Ratio	-0.21	-1.85	-0.10	-2.90	25.21	-5.46
Asset Turnover	0.69	0.49	0.63	0.79	0.82	0.84
Inventory Turnover	3.65	3.04	4.88	4.59	4.13	4.33
Quick Ratio	3.33	1.39	1.26	0.87	1.63	1.58
Current Ratio	7.78	2.75	2.01	1.24	2.22	2.19
Return on Equity (ROE)	1.09%	0.97%	0.97%	13.78%	0.46%	1.66%
Return on Assets (ROA)	1.28%	1.42%	1.71%	9.72%	2.51%	2.70%
Return on Invested Capital (ROIC)	1.84%	2.03%	2.53%	12.03%	3.25%	3.70%
Return on Capital Employed (ROCE)	2.60%	2.90%	3.00%	21.70%	6.70%	7.20%
Earnings Yield	0.56%	0.78%	0.61%	-	-	-
FCF Yield	-3.89%	-4.77%	-28.00%	-	-	-
Buyback Yield / Dilution	-0.47%	-	-40.20%	-20.61%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.